Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;63(2):166-177.
doi: 10.1007/s12016-021-08904-y. Epub 2021 Sep 29.

Antimitochondrial Antibodies: from Bench to Bedside

Affiliations
Review

Antimitochondrial Antibodies: from Bench to Bedside

Francesca Colapietro et al. Clin Rev Allergy Immunol. 2022 Oct.

Abstract

Anti-mitochondrial antibodies (AMA) are directed against the E2 subunits of the 2-oxo acid dehydrogenase complexes (PDC-E2) and are the typical biomarkers of primary biliary cholangitis (PBC), being present in 90-95% of patients, with increasing sensitivity at increasing titers. Albeit being highly specific for PBC diagnosis, AMA can be detected in less than 1% of healthy subjects, and thus the management subjects with no sign or symptom of liver disease is still a challenge and data concerning clinical risk of developing PBC in this subgroup of patients are controversial. Moreover, AMA can also be detected in patients affected by overlap syndrome, as well as hepatic diseases (i.e., NASH and viral hepatitis), while the association with autoimmune diseases, in particular Sjögren's syndrome, systemic sclerosis, and systemic lupus erythematosus, is well established. Furthermore, new associations are being identified with inflammatory myositis and heart disease. AMA are directed towards the pyruvate dehydrogenase multi enzyme complex (PDC-E2) subunit, which represents an epithelial specific autoantigen for PBC. This review focuses on the main characteristics of AMA, their association with autoimmune diseases and liver diseases.

Keywords: Autoimmunity; Myositis; Primary biliary cholangitis; Systemic sclerosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Anti-mitochondrial antibodies detection by indirect immunofluorescence using HEp-2 cell or mouse tissue sections. A AMA staining of mouse kidney/smooth muscle/stomach tissue section showing staining of both proximal and distal tubules of the mouse kidney (upper right) and the parietal cells of the mouse stomach (lower left). B AMA on HEp-2 cells
Fig. 2
Fig. 2
Proposed pathogenetic mechanisms of primary biliary cholangitis APC, antigen presenting cell; PDC-E2, pyruvate dehydrogenase complex; IL, interleukin; IFN, interferon; AMA, anti-mitochondrial antibodies; BEC, biliary epithelial cells

References

    1. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus. N Engl J Med. 2003;349(16):1526–33. doi: 10.1056/NEJMoa021933. - DOI - PubMed
    1. Gulamhusein AF, Hirschfield GM. Pathophysiology of primary biliary cholangitis. Best Pract Res Clin Gastroenterol. 2018;34–35:17–25. doi: 10.1016/j.bpg.2018.05.012. - DOI - PubMed
    1. Bogdanos D-P, Pares A, Baum H, Caballeria L, Rigopoulou EI, Ma Y, et al. Disease-specific cross-reactivity between mimicking peptides of heat shock protein of mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. J Autoimmun. 2004;22(4):353–62. doi: 10.1016/j.jaut.2004.03.002. - DOI - PubMed
    1. Chantran Y, Ballot É, Johanet C. Autoantibodies in primary biliary cirrhosis: Antimitochondrial autoantibodies. Clin Res Hepatol Gastroenterol. 2013;37(4):431–3. doi: 10.1016/j.clinre.2013.05.002. - DOI - PubMed
    1. Calise SJ, Zheng B, Hasegawa T, Satoh M, Isailovic N, Ceribelli A, et al. Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies. Clin Chem Lab Med. 2018;56(10):1789–98. doi: 10.1515/cclm-2017-1152. - DOI - PMC - PubMed